May 27, 2022 UMD Home FabLab AIMLab



Graduate student Xiaolong Luo, a Ph.D. student in the Fischell Department of Bioengineering advised by Maryland NanoCenter Director Gary Rubloff (MSE/ECE/ISR), is conducting research on a ?lab-on-a-chip? microsystem for drug development that could lead to a new strategy for antibiotic therapy.

Antibiotic resistance has been an increasing public health concern. However, few new drugs for bacterial pathogenesis have been obtained without addressing this resistance. One target to solve the arduous problem is "quorum sensing" (QS), a newly-discovered communication system among bacterial cells. In QS, bacterial cell communication is mediated by chemical signals that, when the number of cells reaches a "quorum" level, coordinate changes in gene regulation. The capability to intercept and rewire the biosynthesis of signal molecules, and not kill the bacteria directly, opens the door to discover novel antimicrobial drugs that are able to bypass antibiotic resistance.

Luo's research focuses on developing a microscopic drug research platform that can be used to test potential drugs. By placing QS enzymes in a well-controlled microsystem, the communication signal molecules are reproduced and can be further interrogated. Enzymes placed in site-specific locations in the microsystem have shown normal activity. Next, the microscopic platform is used to screen efficient inhibitors, ultimately the antimicrobial drug candidates, to knock down the production of signal molecules for bacterial communication.

Luo, together with collaborators, has demonstrated a unique platform that integrates biologically active enzymes with microfabricated devices. The enabling capability comes from a biological substance, chitosan. Chitosan can be deposited onto the inorganic surface of microdevices per electrical signal, while retaining reactivity to biological components. The demonstrated platform in Luo's research represents an important step in progress toward a "lab-on-a-chip" technology suitable to support drug development and metabolic engineering research.

| Learn more about Xiaolong Luo in this Fischell Department of Bioengineering profile |



January 27, 2009


«Previous Story  

 

 

Current Headlines

UMD Dedicates IDEA Factory

Engineering at Maryland magazine celebrates the power of philanthropy, impact on students

UMD Inventions of the Year Tackle Grand Challenges

JC Zhao Receives Humboldt Research Award

Maryland Engineering Graduate Programs: Top 10 Public, Four Years in a Row

Safe and Sound

Engineering Faculty Selected for New MPower Seed Grant Funding

International research team sheds light on inner workings of unconventional superconductors

MSE Prof. Liangbing Hu Granted $5.6M in DOE ARPA-E Funding

Brain Freeze: Cryo-FIB-SEM Coming Soon to College Park

 

Colleges A. James Clark School of Engineering
The College of Computer, Mathematical, and Natural Sciences

Communicate Join Email List
Contact Us
Follow us on TwitterTwitter logo

Links Privacy Policy
Sitemap
RSS

Copyright The University of Maryland University of Maryland
2004-2022